Literature DB >> 402803

Transient asymptomatic S-T segment depression during daily activity.

S J Schang, C J Pepine.   

Abstract

The significance of asymptomatic episodes of ischemic type S-T segment depression was studied in 20 patients with coronary heart disease. Continuous 10 hour electrocardiographic recordings accompanied by detailed daily diaries of activity and symptoms were obtained periodically during a mean time of 16 months. All patients had ischemic type S-T depression associated with angina pectoris during treadmill exercise. Measurements of heart rate, S-T depression and exercise level at the onset of angina obtained during repeated controlled exercise tests at the start of each study period were compared with the measurements recorded during daily activity. After 2,826 hours of recording, 411 transient epidsodes of ischemic type S-T depression were noted during usual daily activity. Only 101 (25 percent) of these episodes were associated with angina. The remaining episodes were unrelated to other symptoms or to posture. All occurred at heart rates significantly lower than those observed at the onset of angina during exercise testing. Of these episodes of asymptomatic S-T depression, 72 percent occurred only at rest or during very light activity such as slow walking or sitting. Nitroglycerin administered hourly significantly reduced the frequency of these episodes, thus supporting the concept that they represent painless ischemia. Because the episodes of asymptomatic ischemic type S-T depression occurred more frequently than angina during usual daily activity and were evident at heart rates and activity levels well below those expected to evoke ischemia, they may be caused by factors other than those that cause angina.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 402803     DOI: 10.1016/s0002-9149(77)80095-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  65 in total

1.  Objective assessment of treatment in severe angina.

Authors:  G D Oakley; K M Fox; H J Dargie; A P Selwyn
Journal:  Br Med J       Date:  1979-06-09

2.  Brain mechanisms of stress and depression in coronary artery disease.

Authors:  J Douglas Bremner; Carolina Campanella; Zehra Khan; Negar Fani; Nicole Kasher; Sarah Evans; Collin Reiff; Sanskriti Mishra; Stacy Ladd; Jonathon A Nye; Paolo Raggi; Viola Vaccarino
Journal:  J Psychiatr Res       Date:  2018-11-22       Impact factor: 4.791

3.  Sympathetic neural reactivity to mental stress in humans: test-retest reproducibility.

Authors:  Ida T Fonkoue; Jason R Carter
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-09-23       Impact factor: 3.619

4.  Neurovascular responses to mental stress.

Authors:  Jason R Carter; Nathan T Kupiers; Chester A Ray
Journal:  J Physiol       Date:  2005-02-10       Impact factor: 5.182

Review 5.  Nitrates in silent ischemia.

Authors:  H Purcell; D Mulcahy; K Fox
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

Review 6.  Heart-brain interactions in mental stress-induced myocardial ischemia.

Authors:  Robert Soufer; Hitender Jain; Andrew J Yoon
Journal:  Curr Cardiol Rep       Date:  2009-03       Impact factor: 2.931

Review 7.  ST segment analysis by Holter Monitoring: methodological considerations.

Authors:  Preben Bjerregaard; Amr El-Shafei; Susan L Kotar; Arthur J Labovitz
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-07       Impact factor: 1.468

8.  Nocturnal angina: precipitating factors in patients with coronary artery disease and those with variant angina.

Authors:  A A Quyyumi; J Efthimiou; A Quyyumi; L J Mockus; S G Spiro; K M Fox
Journal:  Br Heart J       Date:  1986-10

Review 9.  The clinical significance of continuous ECG (ambulatory ECG or Holter) monitoring of the ST-segment to evaluate ischemia: a review.

Authors:  Neil J Wimmer; Benjamin M Scirica; Peter H Stone
Journal:  Prog Cardiovasc Dis       Date:  2013-08-16       Impact factor: 8.194

10.  Should we treat silent ischaemic?

Authors:  K M Fox; A A Quyyumi; R D Levy
Journal:  Drugs       Date:  1987       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.